Related Experiment Video
Updated: Jan 24, 2026

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
Published on: May 22, 2014
The signaling adaptor BCAP inhibits NLRP3 and NLRC4 inflammasome activation in macrophages through interactions with
Samuel J Carpentier1, Minjian Ni2, Jeffrey M Duggan2,3
1Department of Microbiology, University of Washington, Seattle, WA 98195, USA.
Abstract:
B cell adaptor for phosphoinositide 3-kinase (PI3K) (BCAP) is a signaling adaptor that activates the PI3K pathway downstream of B cell receptor signaling in B cells and Toll-like receptor (TLR) signaling in macrophages. BCAP binds to the regulatory p85 subunit of class I PI3K and is a large, multidomain protein. We used proteomic analysis to identify other BCAP-interacting proteins in macrophages and found that BCAP specifically associated with the caspase-1 pseudosubstrate inhibitor Flightless-1 and its binding partner leucine-rich repeat flightless-interacting protein 2. Because these proteins inhibit the NLRP3 inflammasome, we investigated the role of BCAP in inflammasome function. Independent of its effects on TLR priming, BCAP inhibited NLRP3- and NLRC4-induced caspase-1 activation, cell death, and IL-1β release from macrophages. Accordingly, caspase-1-dependent clearance of a Yersinia pseudotuberculosis mutant was enhanced in BCAP-deficient mice. Mechanistically, BCAP delayed the recruitment and activation of pro-caspase-1 within the NLRP3/ASC preinflammasome through its association with Flightless-1. Thus, BCAP is a multifunctional signaling adaptor that inhibits key pathogen-sensing pathways in macrophages.
Insights
B cell adaptor for phosphoinositide 3-kinase (BCAP) inhibits inflammasome activation in macrophages. This adaptor protein plays a key role in pathogen sensing and immune responses.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- B cell adaptor for phosphoinositide 3-kinase (BCAP) is a signaling adaptor protein.
- BCAP activates the PI3K pathway downstream of B cell receptor and Toll-like receptor signaling.
- BCAP interacts with the p85 regulatory subunit of class I PI3K.
Purpose of the Study:
- To identify BCAP-interacting proteins in macrophages.
- To investigate the role of BCAP in inflammasome function.
- To elucidate the mechanism by which BCAP regulates inflammasome activation.
Main Methods:
- Proteomic analysis to identify BCAP-interacting proteins.
- Investigated BCAP's role in NLRP3- and NLRC4-induced inflammasome activation.
- Assessed caspase-1 activation, cell death, and IL-1β release in macrophages.
- Utilized BCAP-deficient mice to study Yersinia pseudotuberculosis clearance.
Main Results:
- BCAP specifically associated with Flightless-1 and leucine-rich repeat flightless-interacting protein 2.
- BCAP inhibited NLRP3- and NLRC4-induced caspase-1 activation, cell death, and IL-1β release.
- BCAP-deficient mice showed enhanced clearance of Yersinia pseudotuberculosis.
- BCAP delayed pro-caspase-1 recruitment and activation within the inflammasome.
Conclusions:
- BCAP is a multifunctional signaling adaptor that inhibits key pathogen-sensing pathways in macrophages.
- BCAP's inhibition of inflammasome activation is mediated through its association with Flightless-1.
- BCAP plays a critical role in regulating innate immune responses to bacterial pathogens.
Related Concept Videos
Inhibition of Cdk Activity
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Feedback Inhibition
Interpreting ¹H NMR Signal Splitting: The (n + 1) Rule
Yeast Signaling
Enzyme Inhibition

